New Science Ventures (NSV) is a venture capital firm that funds companies leveraging groundbreaking science to address market needs. They invest in early to mid-stage firms in biotech, health tech, data analytics, and business intelligence, with investment amounts ranging from $500,000 to $10 million. Founded in 2004 by Somu Subramaniam and Tom Lavin, NSV manages over $700 million in assets. Notable investments include Novadip Biosciences and Zeotap.
